The Posters and Presentations session is organized in partnership with the LEEM (Les Entreprises du Médicament).
Agenda – DECEMBER 2nd
| TIME | COMPANY | SPEAKER | POSITION | TITLE |
| 2.00pm | ABUNDNZ | Robert-Jan LAMERS | Managing Director | Ultrasensitive assay for bioanalytical studies with innovative medicines |
| 2.15pm | CAPSULAE | Victor ROULLIER | Project Manager | Microencapsulation as a solution for therapeutic applications |
| 2.30pm | CYANAGEN | Rossana PERCIACCANTE | R&D Manager | Novel fluorescent IR-marker for monitoring the kidney function |
| 2.45pm | VITAMFERO | Pascal BRETON | Chief Executive Officer | VitamFero : a novel generation of veterinary live attenuated prophylactic treatments. |
| 3.00pm | DELPHI GENETICS | Cédic SZPIRER | CEO / CSO | The Staby® technology: No antibiotics and higher yields in recombinant proteins, pDNA productions and antibody development |
| 3.15pm | IMSTAR | Françoise SOUSSALINE | President & CEO | Innovative Image Cytometry Solutions for biomarkers identification and validation in research and cyto-pathology |
| 4.00pm | INMOTE MEDTECH | Bart Groothuijze | CEO | Inmote MedTech: Easy, secure and consistent documentation in woundcare |
| 4.15pm | JAGIELLONIAN UNIVERSITY | Radoslaw RUDZ | Head of Innovation Team CITTRU | Novel antiviral agents against coronaviruses |
| 4.30pm | OCR | Matthieu DUBRUQUE | COO | OCR – The OneHealth Company |
| 4.45pm | QUINTEN | Quentin PERRON | Head of Chemistry | Quinten: Expert in strategic data leveraging. |
| 5.00pm | 2BIND | Thomas SCHUBERT | CEO | Fast and quantitative analysis of molecular interactions using the MicroScale Thermophoresis (MST) |
| 5.15pm | 3M | Catherine BINEAU | Laboratory Engineer Life Science Specialist | 3M EMPHAZE AEX HYBRID PURIFIER: Purification to the next level |
| 5.30pm | 4P PHARMA | Itschak LAMENSDORF | Chief Scientific Officer | Translating science to product: General methodolodgy for addressing technological and financial Challenges |
